Dr. Carteron is a board-certified rheumatologist and internist with international expertise in Sjogren’s disease. She trained in molecular virology and cellular immunology, received her MD from Johns Hopkins, with post-graduate clinical and research training at Johns Hopkins, Duke, Stanford and University of California, San Francisco. Dr. Carteron is also a Clinical Professor of Medicine in the Division of Rheumatology at UCSF, precepting rheumatology fellows.

Following almost 30 years of private practice in San Francisco focused on complex autoimmune disease and transplant immunology, she joined Drs. Nancy McNamara and Ava Wu as a Consultative Rheumatologist in the Sjogren’s Clinic.

Website: https://nancycarteronmd.com

– Immediate past chair, Medical & Scientific Advisory group, Sjogren’s Foundation
– Co-founder and current board member, HealthWell Foundation
– Guideline oversight leadership committee, Sjogren’s Foundation

Pathogenesis of Sjogren’s disease; Immunology of autoimmunity; Clinical Guidelines for Sjogren’s

Carteron NL, Wofsy D, Seaman WE. Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+ cells. J Immunology 140:713-716, 1988. PMID:2448372

Carteron NL, Wofsy D, Schimenti CL, Ermak TH. F(ab')2 anti-CD4 monoclonal antibodies inhibit the accumulation of CD4+ T cells, CD8+ T cells, and B cells in the kidneys of lupus-prone NZB/NZW mice. Clin Immunol Immunopath 56:373-383, 1990. PMID:1975226

Carteron NL. Cytokines in rheumatoid arthritis: trials and tribulations. Molecular Medicine Today 6:315-323, 2000. PMID:10904249

Fremes R, Carteron N. A Body Out of Balance: Understanding and Treating Sjögren's Syndrome. Avery, Penguin Group Inc, NY, NY, 184 pages, 2003. Written from both patient and physician perspective.

Carsons SE, Vivino FB, Parke A, Carteron N, Sankar V, Braisington R, Brennan MT, Ehlers W, Fox R, Scofield H, Hammitt KM, Birnbaum J, Kassan S, Mandel S. Treatment Guidelines for Rheumatologic Manifestations of Sjogren's Syndrome: Use of Biologic Agents, Management of Fatigue and Inflammatory Musculoskeletal Pain. Arthritis Care Res (Hoboken). 2017 Apr;69(4):517-527. PMID:27390247

Lee AS, Scofield RH, Hammitt KM, Gupta N, Thomas D, Mousa T, Ussavarungsi K, St Clair EW, Meehan R, Dunleavy K, Makara M, Carsons S and Carteron N. Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjogren's. CHEST 159(2):683-698, 2021. PMID:33075377.

Carteron N. Associate Editor, The Sjogren's Book, Fifth edition. Wallace D (ed), Oxford University Press, New York, NY, 2022, and author of Chap 32: Management of Fatigue in Sjogren's, pp 318-323.

Noaiseh G, Deboo A, King JK, Varadhachary A, Sarka G, Goodman B, Hammitt KM, Frantsve-Hawley J, Fox R, Baker MC, Danielides S, Mandel S, Pavlakis P, Scofield RH, Wallace DJ, Carteron N and Carsons S. Recommendations for Aligned Nomenclature of Peripheral Nervous System Disorders Across Rheumatology and Neurology. Arthritis Rheumatol. 2025 Jan 6;77(4):383-389. PMID:39489692

Deboo A, Fox R, Hammitt KM, Frantsve-Hawley J, Baker MC, Danielides S, DeSousa E, Goodman BP, King JK, Mandel, S, Noaiseh G, Pavlakis PP, Sarka G, Scofield RH, Varadhachary A, Wallace DJ, Makara M, Carteron N and Carsons S. Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjogren's Disease. Arthritis Care Res (Hoboken), 2025.doi:10.1002/acr.70004. PMID:41327784